Researchers from NASA and are using human stem cells to measure the effects of deep space radiation.
Using mice transplanted with human stem cells, the research team has demonstrated for the first time that the radiation encountered in deep space travel may increase the risk of leukaemia in humans.
"Our results are troubling because they show radiation exposure could potentially increase the risk of leukaemia in two ways," said Christopher Porada, associate professor at Wake Forest Institute for Regenerative Medicine in the US.
Radiation exposure is believed to be one of the most dangerous aspects of travelling to Mars, according to NASA.
The average distance to the red planet is 140 million miles, and a roundtrip could take three years.
The goal of the study was to assess the direct effects of simulated solar energetic particles (SEP) and galactic cosmic ray (GCR) radiation on human hematopoietic stem cells (HSCs).
These stem cells comprise less than 0.1 per cent of the bone marrow of adults, but produce the many types of blood cells that circulate through the body and work to transport oxygen, fight infection, and eliminate any malignant cells that arise.
Researchers then performed laboratory and animal studies to define the impact of the exposure.
These exposure levels that simulated deep space radiation were found to dramatically affect the health and function of the HSCs.
"Radiation exposure at these levels was highly deleterious to HSC function, reducing their ability to produce almost all types of blood cells, often by 60-80 per cent," said Porada.
Previous studies by other researchers had already demonstrated that exposure to high doses of earthly radiation, such as from X-rays, can have harmful and life-threatening effects on the body's ability to make blood cells,
It can significantly increase the likelihood of cancers, especially leukaemias.
However, the new study was the first to show a damaging effect of low, mission-relevant doses of space radiation.
The study was published in the journal Leukaemia.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
